Patent · US Active

Triazolopyridazine

US9422290B2 · kind B2 · utility

2Cited by

0References

17Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Harald Engelhardt · Ebreichsdorf, AT
Davide Gianni · Wien, AT
Dirk Kessler · Wien, AT
Ulrich Reiser · Wien, AT
Christian Alan Paul Smethurst · Wien, AT
Andreas Steffen · Wien, AT

Key dates

Filing date	Nov 11, 2013
Grant date	Aug 23, 2016
Priority date	—
Expiry date	Nov 11, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds of general formula (I)wherein the groups R1 to R3 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.